Do Options Traders Know Something About Viemed Stock We Don't?
Investors need to pay close attention to VMD stock based on the movements in the options market lately.
VMD - Viemed Healthcare, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.00
DETAILS
HIGH:
$14.00
LOW:
$14.00
MEDIAN:
$14.00
CONSENSUS:
$14.00
UPSIDE:
47.68%
Stock News
Viemed Healthcare, Inc. to Present at the 20th Annual LD Micro Main Event
Lafayette, Louisiana--(Newsfile Corp. - October 6, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Viemed Healthcare, Inc. is scheduled to present on Tuesday, October 20, 2026 at 12:30 PM PT.
Viemed Healthcare: Improving Capital Efficiency Creates A Strong Buy Opportunity
Viemed Healthcare (VMD) is evolving from a capital-intensive respiratory equipment company into a diversified, capital-light home healthcare provider. VMD's expansion into sleep, resupply, and women's health segments is driving robust revenue growth while reducing capital intensity and supporting free cash flow acceleration. Despite margin compression from the new business mix, VMD needs only 0.5% annual free cash flow growth to justify its current valuation, offering a strong margin of safety.
Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands
Viemed Healthcare NASDAQ: VMD outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions.
Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Viemed Healthcare Q2 Earnings Call Highlights
Viemed Healthcare NASDAQ: VMD reported record second-quarter revenue as growth in its ventilator business resumed under the updated Medicare coverage framework and newer service lines expanded.
Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago.
Viemed Healthcare Announces Second Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and six months ended June 30, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2026 were $78.1 million, setting a Company record, representing an increase of $15.0 million, or 23.9%, compared with the prior-year quarter and an increase of approximately 3.6% sequentially.
Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Second Quarter 2026 Earnings Conference Call on Tuesday, August 4, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=peVp8cbE Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Surgery Partners operates a massive nationwide network of outpatient surgical facilities and hospitals. Viemed Healthcare is a high-growth specialist focusing on home-based respiratory care and disease management.
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago.
Viemed Healthcare Announces First Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025.
Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details
LAFAYETTE, LA / ACCESS Newswire / April 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its First Quarter 2026 Earnings Conference Call on Wednesday, May 6, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=MWjE55eM Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.
Michael Moore Sells 31,570 Shares of Viemed Healthcare (NASDAQ:VMD) Stock
Viemed Healthcare, Inc. (NASDAQ: VMD - Get Free Report) President Michael Moore sold 31,570 shares of the firm's stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $9.42, for a total value of $297,389.40. Following the completion of the sale, the president directly owned 1,691,044 shares of the
Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
LAFAYETTE, LA / ACCESS Newswire / March 16, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced it will present and host one-on-one meetings with investors at Sidoti's Small-Cap Virtual Investor Conference, taking place on March 18-19, 2026. The presentation will begin at 1:45 p.m.
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025
Dallas, Texas--(Newsfile Corp. - March 11, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Viemed Healthcare Announces 2026 Share Repurchase Program
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has authorized a share repurchase program effective through March 2027. Under the share repurchase program, which constitutes a normal course issuer bid under applicable Canadian securities laws, Viemed may purchase up to 1,930,131 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 4, 2026.